Board Members

Dr. Gerald S. Post, DVM, ACVIM (Oncology), ACF Founder and Chairman

Dr. Post, Chairman and Founder of the Animal Cancer Foundation, is one of approximately one hundred board-certified veterinary oncologists in the United States. He has over a decade of clinical experience treating pets with cancer and in 1997 formed the Veterinary Oncology and Hematology Center, a highly successful private veterinary oncology practice. Dr. Post graduated with distinction from Cornell University in 1983 and received his DVM degree from the University of Minnesota in 1988. In 1991, he completed a residency in Oncology at the Animal Medical Center in New York and in 1992 became a Diplomate of the American College of Veterinary Internal Medicine. Dr. Post has devoted his life to animals and has always had a strong interest in small animal oncology. He is also an active supporter of endangered species conservation and is the founder of Endangered Encounters, LLC, a travel and conservation company which allows people to experience endangered animals in the wild, while simultaneously aiding their conservation. As the number of pets diagnosed with cancer escalates, Dr. Post believes the next breakthrough in cancer therapy for people and pets will come in the form of molecular targeted therapy, or gene therapy, as opposed to conventional chemotherapy. Dr. Post initiated the Animal Cancer Foundation to serve as the integral link between the millions of pets with cancer and the biotechnology community. It is his hope that by working together, we can more effectively treat cancer in our beloved pets and more efficiently and economically trial new therapeutics that will also prove effective in the treatment of human cancer.

Dr. Kelly Posner Gerstenhaber
Dr. Posner Gerstenhaber graduated from Brown University with honors and went on to earn a Ph.D. in Clinical Psychology at Yeshiva University, after completing her doctoral research in pediatric oncology
at the Memorial Sloan-Kettering Cancer Center. She then did an internship and fellowship at Babies' Hospital, Department of Child Psychiatry, Columbia-Presbyterian Medical Center.

Dr. Posner Gerstenhaber is a research scientist and the Director of Clinical Services of the Research Unit for Pediatric Psychopharmacology, at New York State Psychiatric Institute, Columbia University.
In addition to her research responsibilities, which include running a number of pediatric clinical trials for industry and the NIMH, Dr. Gerstenhaber also teaches and directs a training program.

Philanthropy has always been very much a priority and driving force for Dr. Gerstenhaber. She has always been actively involved in health care issues, particularly as they apply to children's needs, and the advancement of medical treatments and technology. Relatedly, she has been an integral part of the Foundation for Huntington's Disease. As part of this international research team (consisting of the neurology depts. of Harvard, Columbia, and others) that discovered the genetic marker for Huntington's disease, Dr. Posner-Gerstenhaber has traveled to Venezuela on multiple occasions. Consequently, she has spear-headed the addition of evaluation services for this very disadvantaged third world child population and single-handedly collected (from industry and providers) and made available greatly-needed psychotropic medications for these suffering children and adolescents. Dr. Posner-Gerstenhaber was also appointed to the first Young Leadership Council of the World Jewish Congress, of which she chaired the Nationalism Committee. She has also just been appointed the New York Chair of the Jewish International Health Care Division of the UJA.

Dr. Posner-Gerstenhaber is quite committed to ACF in part because with its progressive vision and preliminary contributions it is consistent with her interest in forwarding medical treatments and care of animals as well as humans. Such awareness was the result of personal experience with the ACF. With her academic and medical background, Dr. Posner-Gerstenhaber conducted exhaustive research in order to discover the best treatment for her golden-retriever, diagnosed last year with cancer. This led her to the ACF and its progressive and comprehensive approach has certainly contributed to the wonderful care and prognosis her dog has experienced thus far. As the loving owner of two Goldens, an animal lover, and one quite dedicated to the advancement of science and medical care, the visionary approach of the ACF is a foundation to which she is greatly committed.

Steven A. Humphrey, CFRE
Mr. Humphrey has spent his career in the two hundred and fifty billion dollar not-for-profit industry. As a master fundraiser, he has been responsible, directly and indirectly, for raising over a billion dollars for mission driven charitable causes. As an eagle scout and certified fundraising executive, he spent two decades in senior staff leadership roles with the Boy Scouts of America in Chicago; Green Bay, Wisconsin; New York City and Long Island, New York. Other successful affiliations include: The American Red Cross, the Long Island headquartered Guide Dog Foundation for the Blind, the New York City based Center for Urban Community Services and the Caron Foundation. Steven also serves as a principal in the Stevens Group, a lower Manhattan based travel and technology consulting practice.

David J. Waters, DVM, PhD
Dr. Waters is a board-certified veterinary surgeon and expert in the prostate cancers and skeletal neoplasms of pet dogs. He is currently Professor of Surgery and Comparative Oncology at Purdue University and the Executive Director of the Gerald P. Murphy Cancer Foundation. Dr. Waters received his degree in Biological Science from Cornell University in 1980 and his DVM degree from Cornell in 1984. In 1990, he became a Diplomate of the American College of Veterinary Surgeons. In 1992, he received his PhD degree in Veterinary Surgery from the University of Minnesota. Dr. Waters joined the faculty of the Department of Veterinary Clinical Sciences at Purdue University in 1991
as Assistant Professor of Surgery and was promoted to Associate Professor in 1996. He serves as
Co-Director of the Purdue Comparative Oncology Program and is Associate Director of the Purdue Center on Aging and the Life Course. Dr. Waters is the author of over 100 scientific manuscripts, abstracts and textbook chapters. His current research focuses on the evaluation of novel anticancer therapies, strategies for cancer prevention and biomarkers of mammalian aging and cancer risk.

Kim Williams
After joining the NFL as Chief Financial Officer in 2003, Kim Williams was named Chief Operating Officer of NFL Network by NFL Network President & CEO Steve Bornstein in April 2006.

Williams is responsible for the day-to-day management of advertising and affiliate sales, network operations and administration, plus oversight of all financial controls and revenue.

With the NFL’s January 2006 decision to award the Thursday-Saturday primetime NFL game package to NFL Network, Williams plays a critical role in ensuring its success.

Prior to her current position, Williams served as Senior Vice President, Finance for the NFL, helping in the initial launch of NFL Network and responsible for the League’s overall financial activities including financial reporting and analysis, financial routines and controls, and long-range strategic planning.

Preceding her time at the NFL, Williams served as Senior Vice President & Chief Financial Officer for NBC West Coast, where she reported to then NBC Entertainment President Jeff Zucker. In that role, Williams worked at NBC’s Burbank, Calif., offices and was responsible for all financial aspects of NBC West Coast operations, including NBC’s Entertainment, Studios & Enterprises divisions.

Williams also worked in New York as the Vice President and Chief Financial Officer for NBC Business Development. In this capacity, Williams oversaw activities including acquisition/divestiture analyses, investment portfolio management, and derivative/hedging strategies.

In all, Williams spent more than a decade with General Electric (GE) owned companies, including stays at Nuovo Pignone (GE Power Systems) in Florence, Italy, and GE International, Power Controls and GE Capital in London, England.

Williams holds a BA degree from Connecticut College in Japanese and Asian studies. She also has a Masters degree in international business administration from the American Graduate School of International Management (“Thunderbird”).